Publications by authors named "Emily Gelber"
Treatment Patterns for Sickle Cell Disease among Those with Cerebrovascular Disease in the USA.
Cerebrovasc Dis
December 2023
Background: New treatments and guidelines in sickle cell disease (SCD) have improved the quality and lifespan of SCD patients. Over 90% of people with SCD will live into adulthood, and the majority will live past 50 years of age. However, data on comorbidities and treatments among SCD patients with and without cerebrovascular disease (CVD) are limited.
View Article and Find Full Text PDFArticle Synopsis
- * TTS allowed participants to remain in school if they were asymptomatic, masked, practiced physical distancing, and underwent regular COVID-19 testing after exposure, with 90 schools implementing the strategy during a specified period in late 2021.
- * During TTS implementation, the secondary attack risk for COVID-19 transmission was low (1.5%), with most cases limited to students and no evidence of further transmission in schools, saving up to